References
- Abd El Atti RM, Abou Gabal HH, Osman WM, et al (2013). Insights into the prognostic value of DJ-1 and MIB-1 in astrocytic tumors. Diagn Pathol, 8, 126. https://doi.org/10.1186/1746-1596-8-126
- Armstrong TS, Vera-Bolanos E, Bekele BN, et al (2010). Adult ependymal tumors: prognosis and the M.D. anderson cancer center experience. Neuro Oncol, 12, 862-70. https://doi.org/10.1093/neuonc/noq009
- Bowers DC (2003). Study of the MIB-1 labeling index as a predictor of tumor progression in pilocytic astrocytomas in children and adolescents. J Clin Oncol, 21, 2968-73. https://doi.org/10.1200/JCO.2003.01.017
-
Bredel M, Piribauer M, Marosi C, et al (2002). High expression of DNA topoisomerase
$II\alpha$ and Ki-67 antigen is associated with prolonged survival in glioblastoma patients. European J Cancer, 38, 1343-7. https://doi.org/10.1016/S0959-8049(02)00065-5 - Chiang MDH, Ting ML-T, Hsu MDMHAC-Y, et al (2003). MIB-1 and DNA topoisomerase IIa could be helpful for predicting long-term survival of patients with glioblastoma. Am J Clin Pathol, 119, 715-22. https://doi.org/10.1309/UN4WV65UH94JEWUV
- Coons SW, Johnson PC, Pearl DK (1997). The prognostic significance of Ki-67 labeling indices for oligodendrogliomas. Neurosurgery, 41, 878-85. https://doi.org/10.1097/00006123-199710000-00021
- Dang YW, Zeng J, He RQ, et al (2014). Effects of miR-152 on cell growth inhibition, motility suppression and apoptosis induction in hepatocellular carcinoma cells. Asian Pac J Cancer Prev, 15, 4969-76. https://doi.org/10.7314/APJCP.2014.15.12.4969
- Dehghani F, Schachenmayr W, Laun A, et al (1998). Prognostic implication of histopathological, immunohistochemical and clinical features of oligodendrogliomas: a study of 89 cases. Acta Neuropathologica, 95, 493-504. https://doi.org/10.1007/s004010050830
- Donato V, Papaleo A, Castrichino A, et al (2007). Prognostic implication of clinical and pathologic features in patients with glioblastoma multiforme treated with concomitant radiation plus temozolomide. Tumori, 93, 248.
- Ellison DW, Steart PV, Bateman AC, et al (1995). Prognostic indicators in a range of astrocytic tumours: an immunohistochemical study with Ki-67 and p53 antibodies. J Neurol Neurosurg Psychiatry, 59, 413-9. https://doi.org/10.1136/jnnp.59.4.413
- Fakhrjou A, Dastranj-Tabrizi A, Ghojazadeh M, et al (2013). Diagnostic value of protein Ki67 (MIB-1) in atypical Pap smears of postmenopausal women. Asian Pac J Cancer Prev, 14, 4815-8. https://doi.org/10.7314/APJCP.2013.14.8.4815
- Figarella-Branger D, Civatte M, Bouvier-Labit C, et al (2000). Prognostic factors in intracranial ependymomas in children. J Neurosurg, 93, 605-13. https://doi.org/10.3171/jns.2000.93.4.0605
- Habberstad AH, Gulati S, Torp SH (2011). Evaluation of the proliferation markers Ki-67/MIB-1, mitosin, survivin, pHH3, and DNA topoisomerase IIa in human anaplastic astrocytomas-an immunohistochemical study. Diagn Pathol, 6, 43. https://doi.org/10.1186/1746-1596-6-43
- Haroon S, Hashmi AA, Khurshid A, et al (2013). Ki67 index in breast cancer: correlation with other prognostic markers and potential in pakistani patients. Asian Pac J Cancer Prev, 14, 4353-8. https://doi.org/10.7314/APJCP.2013.14.7.4353
- Heegaard S, Sommer HM, Broholm H, et al (1995). Proliferating cell nuclear antigen and Ki-67 immunohistochemistry of oligodendrogliomas with special reference to prognosis. Cancer, 76, 1809-13. https://doi.org/10.1002/1097-0142(19951115)76:10<1809::AID-CNCR2820761020>3.0.CO;2-I
- Hernandez-Pedro NY, Rangel-Lopez E, Magana-Maldonado R, et al (2013). Application of nanoparticles on diagnosis and therapy in gliomas. Biomed Res Int, 2013, 351031.
- Higgins J, Thompson SG (2002). Quantifying heterogeneity in a meta-analysis. Statistics in medicine, 21, 1539-58. https://doi.org/10.1002/sim.1186
- Ho DM-T, Hsu C-Y, Wong T-T, et al (2001). A clinicopathologic study of 81 patients with ependymomas and proposal of diagnostic criteria for anaplastic ependymoma. J Neuro-Oncol, 54, 77-85. https://doi.org/10.1023/A:1012590505236
- Hu X, Miao W, Zou Y, et al (2013). Expression of p53, epidermal growth factor receptor, Ki-67 and O6-methylguanine-DNA methyltransferase in human gliomas. Oncol Letters, 6, 130-4.
- Huang S, Chen G (2014). Overexpression of DcR3 and its significance on tumor cell differentiation and proliferation in glioma. Scientific World J, 2014, 605236.
- Huang T, Jin X, He L, et al (2013). Role of podocalyxin in astrocytoma: clinicopathological and evidence. Oncol Lett, 6, 1390-6.
- Jaros E, Perry R, Adam L, et al (1992). Prognostic implications of p53 protein, epidermal growth factor receptor, and Ki-67 labelling in brain tumours. Br J Cancer, 66, 373. https://doi.org/10.1038/bjc.1992.273
- Kanamori M, Kumabe T, Sonoda Y, et al (2008). Predictive factors for overall and progression-free survival, and dissemination in oligodendroglial tumors. J Neuro-Oncol, 93, 219-28.
- Kleinschmidt-DeMasters BK, Meltesen L, McGavran L, et al (2006). Characterization of glioblastomas in young adults. Brain Pathology, 16, 273-86. https://doi.org/10.1111/j.1750-3639.2006.00029.x
- Kohler BA, Ward E, McCarthy BJ, et al (2011). Annual report to the nation on the status of cancer, 1975-2007, featuring tumors of the brain and other nervous system. J Natl Cancer Inst, 103, 714-36 https://doi.org/10.1093/jnci/djr077
- Kouri FM, Jensen SA, Stegh AH (2012). The role of Bcl-2 family proteins in therapy responses of malignant astrocytic gliomas: Bcl2L12 and beyond. Scientific World J, 2012, 838916.
- Kros JM, Hop WC, Godschalk JJ, et al (1996). Prognostic value of the proliferation-related antigen Ki-67 in oligodendrogliomas. Cancer, 78, 1107-13. https://doi.org/10.1002/(SICI)1097-0142(19960901)78:5<1107::AID-CNCR22>3.0.CO;2-5
- Kuo LT, Kuo KT, Lee MJ, et al (2009). Correlation among pathology, genetic and epigenetic profiles, and clinical outcome in oligodendroglial tumors. Int J Cancer, 124, 2872-9. https://doi.org/10.1002/ijc.24303
- Laks DR, Masterman-Smith M, Visnyei K, et al (2009). Neurosphere formation is an independent predictor of clinical outcome in malignant glioma. Stem Cells, 27, 980-7. https://doi.org/10.1002/stem.15
- Lau J, Ioannidis JP, Schmid CH (1997). Quantitative synthesis in systematic reviews. Ann Intl Med, 127, 820-6. https://doi.org/10.7326/0003-4819-127-9-199711010-00008
- Li S-W, Qiu X-G, Chen B-S, et al (2009). Prognostic factors influencing clinical outcomes of glioblastoma multiforme. Chin Med J, 122, 1245-9.
- Liu Y, Tang K, Yan W, et al (2013). Identifying Ki-67 specific miRNA-mRNA interactions in malignant astrocytomas. Neuroscience Letters, 546, 36-41. https://doi.org/10.1016/j.neulet.2013.04.030
- Margraf LR, Gargan L, Butt Y, et al (2011). Proliferative and metabolic markers in incompletely excised pediatric pilocytic astrocytomas-an assessment of 3 new variables in predicting clinical outcome. Neuro Oncol, 13, 767-74. https://doi.org/10.1093/neuonc/nor041
- McKeever PE, Strawderman MS, Yamini B, et al (1998). MIB- 1 proliferation index predicts survival among patients with grade II astrocytoma. J Neuropathol Exp Neurol, 57, 931-6. https://doi.org/10.1097/00005072-199810000-00005
- Montine TJ, Vandersteenhoven JJ, Aguzzi A, et al (1994). Prognostic significance of Ki-67 proliferation index in supratentorial fibrillary astrocytic neoplasms. Neurosurgery, 34, 674-9. https://doi.org/10.1227/00006123-199404000-00016
- Nabika S, Kiya K, Satoh H, et al (2010). Prognostic significance of expression patterns of EGFR family, p21 and p27 in high-grade astrocytoma. Hiroshima J Med Sci, 59, 65-70.
- Nazarenko I, Hede SM, He X, et al (2012). PDGF and PDGF receptors in glioma. Ups J Med Sci, 117, 99-112. https://doi.org/10.3109/03009734.2012.665097
- Neder L, Colli B, Machado H, et al (2003). MIB-1 labeling index in astrocytic tumors-a clinicopathologic study. Clin Neuropathol, 23, 262-70. https://doi.org/10.1046/j.1440-1789.2003.00510.x
- Okita Y, Narita Y, Miyakita Y, et al (2012). Pathological findings and prognostic factors in recurrent glioblastomas. Brain Tumor Pathol, 29, 192-200. https://doi.org/10.1007/s10014-012-0084-2
- Park KJ, Kang SH, Park DH, et al (2012). Usefulness of thallium-201 SPECT for prediction of early progression in low-grade astrocytomas diagnosed by stereotactic biopsy. Clin Neurol Neurosurg, 114, 223-9. https://doi.org/10.1016/j.clineuro.2011.10.023
- Parmar MK, Torri V, Stewart L (1998). Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med, 17, 2815-34. https://doi.org/10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8
- Phi JH, Wang KC, Park SH, et al (2012). Pediatric infratentorial ependymoma: prognostic significance of anaplastic histology. J Neurooncol, 106, 619-26. https://doi.org/10.1007/s11060-011-0699-x
- Pollack IF, Campbell JW, Hamilton RL, et al (1997). Proliferation index as a predictor of prognosis in malignant gliomas of childhood. Cancer, 79, 849-56. https://doi.org/10.1002/(SICI)1097-0142(19970215)79:4<849::AID-CNCR23>3.0.CO;2-Z
- Pollack IF, Hamilton RL, Burnham J, et al (2002). Impact of proliferation index on outcome in childhood malignant gliomas: results in a multi-institutional cohort. Neurosurgery, 50, 1238-45.
- Preusser M, Hoeftberger R, Woehrer A, et al (2012). Prognostic value of Ki67 index in anaplastic oligodendroglial tumours--a translational study of the European organization for research and treatment of cancer brain tumor group. Histopathology, 60, 885-94. https://doi.org/10.1111/j.1365-2559.2011.04134.x
- Preusser M, Wolfsberger S, Czech T, et al (2005). Survivin expression in intracranial ependymomas and its correlation with tumor cell proliferation and patient outcome. Am J Clin Pathol, 124, 543-9. https://doi.org/10.1309/PP2G5GAAFKV82DTG
- Qiang J, Wei Z, Xiao-Guang Q, et al (2011). Gene expression profiling reveals Ki-67 associated proliferation signature in human glioblastoma. Chinese Med J Beijing, 124, 2584.
- Reavey-Cantwell JF, Haroun RI, Zahurak M, et al (2001). The prognostic value of tumor markers in patients with glioblastoma multiforme: analysis of 32 patients and review of the literature. J Neuro-Oncol, 55, 195-204. https://doi.org/10.1023/A:1013845004294
- Ritter AM, Hess KR, McLendon RE, et al (1998). Ependymomas: MIB-1 proliferation index and survival. J Neurooncol, 40, 51-7. https://doi.org/10.1023/A:1006082622699
- Rodriguez-Pereira C, Suarez-Penaranda J, Vazquez-Salvado M, et al (2000). Value of MIB-1 labelling index (LI) in gliomas and its correlation with other prognostic factors. A clinicopathologic study. J Neurosurg Sci, 44, 203-9; discussion 9-10.
- Shen C, Yang L, Yuan X (2011). Endothelin B receptor expression in human astrocytoma: association with clinicopathological variables and survival outcomes. Int J Neurosci, 121, 626-31. https://doi.org/10.3109/00207454.2011.602808
- Tadbir AA, Pardis S, Ashkavandi ZJ, et al (2012). Expression of Ki67 and CD105 as proliferation and angiogenesis markers in salivary gland tumors. Asian Pac J Cancer Prev, 13, 5155-9. https://doi.org/10.7314/APJCP.2012.13.10.5155
- Tian B, Zhang Y, Zhang J (2014). Periostin is a new potential prognostic biomarker for glioma. Tumour Biol, 35, 5877-83. https://doi.org/10.1007/s13277-014-1778-3
- Torp S, Helseth E, Dalen A, et al (1992). Relationships between Ki-67 labelling index, amplification of the epidermal growth factor receptor gene, and prognosis in human glioblastomas. Acta Neurochirurgica, 117, 182-6. https://doi.org/10.1007/BF01400618
- Tove L-L, Hansson HA, Stein S, et al (2012). Prognostic value of histological features in diffuse astrocytomas WHO grade II. Interl J Clin Experimental Pathol, 5, 152.
- Uematsu M, Ohsawa I, Aokage T, et al (2005). Prognostic significance of the immunohistochemical index of survivin in glioma: a comparative study with the MIB-1 index. J Neurooncol, 72, 231-8. https://doi.org/10.1007/s11060-004-2353-3
- Watanabe Y, Yamasaki F, Kajiwara Y, et al (2010). Expression of phosphoprotein enriched in astrocytes 15 kDa (PEA-15) in astrocytic tumors: a novel approach of correlating malignancy grade and prognosis. J Neurooncol, 100, 449-57. https://doi.org/10.1007/s11060-010-0201-1
- Wen PY, Kesari S (2008). Malignant gliomas in adults. New England J Med, 359, 492-507. https://doi.org/10.1056/NEJMra0708126
- Wessels PH, Hopman AH, Kubat B, et al (2003). Proliferation and aneusomy predict survival of young patients with astrocytoma grade II. Br J Cancer, 89, 128-34. https://doi.org/10.1038/sj.bjc.6601067
- Westermark B (2012). Glioblastoma-a moving target. Ups J Med Sci, 117, 251-6. https://doi.org/10.3109/03009734.2012.676574
- Yang P, Wang Y, Peng X, et al (2013). Management and survival rates in patients with glioma in China (2004-2010): a retrospective study from a single-institution. J Neurooncol, 113, 259-66. https://doi.org/10.1007/s11060-013-1103-9
- Yoshida Y, Nakada M, Harada T, et al (2010). The expression level of sphingosine-1-phosphate receptor type 1 is related to MIB-1 labeling index and predicts survival of glioblastoma patients. J Neurooncol, 98, 41-7. https://doi.org/10.1007/s11060-009-0064-5
- Yue Q, Zhang X, Ye HX, et al (2014). The prognostic value of Foxp3+ tumor-infiltrating lymphocytes in patients with glioblastoma. J Neurooncol, 116, 251-9. https://doi.org/10.1007/s11060-013-1314-0
- Zamecnik J, Snuderl M, Eckschlager T, et al (2003). Pediatric intracranial ependymomas: prognostic relevance of histological, immunohistochemical, and flow cytometric factors. Modern Pathol, 16, 980-91. https://doi.org/10.1097/01.MP.0000087420.34166.B6
- Zawrocki A, Izycka-Swieszewska E, Papierz W, et al (2011). Analysis of the prognostic significance of selected morphological and immunohistochemical markers in ependymomas, with literature review. Folia Neuropathol, 49, 94-102.
- Zhao S, Wu J, Wang C, et al (2013). Intraoperative fluorescenceguided resection of high-grade malignant gliomas using 5-aminolevulinic acid-induced porphyrins: a systematic review and meta-analysis of prospective studies. PLoS One, 8, e63682. https://doi.org/10.1371/journal.pone.0063682
- Zhong D, Li X, Zhang G (2001). Multivariate analysis of the parameters related to prognosis of astrocytoma. Zhonghua Bing Li Xue Za Zhi Chinese J Pathol, 30, 345-9.
Cited by
- Expression of Vimentin and Ki-67 Proteins in Cervical Squamous Cell Carcinoma and their Relationships with Clinicopathological Features vol.16, pp.10, 2015, https://doi.org/10.7314/APJCP.2015.16.10.4271
- Central, Extraventricular and Atypical Neurocytomas: a Clinicopathologic Study of 35 Cases from Pakistan Plus a Detailed Review of the Published Literature vol.17, pp.3, 2016, https://doi.org/10.7314/APJCP.2016.17.3.1565
- Epidermal Growth Factor Receptor and Ki-67 Expression in Canine Gliomas vol.53, pp.6, 2016, https://doi.org/10.1177/0300985816644301
- (Pro)renin receptor is crucial for glioma development via the Wnt/β-catenin signaling pathway vol.127, pp.4, 2017, https://doi.org/10.3171/2016.9.JNS16431
- Value of the visual and semiquantitative analysis of carbon-11-methionine PET/CT in brain tumors’ recurrence versus post-therapeutic changes vol.38, pp.12, 2017, https://doi.org/10.1097/MNM.0000000000000754
- Prognostic relevance of NG2/CSPG4, CD44 and Ki-67 in patients with glioblastoma vol.39, pp.9, 2017, https://doi.org/10.1177/1010428317724282
- Cut-point for Ki-67 proliferation index as a prognostic marker for glioblastoma pp.17437555, 2019, https://doi.org/10.1111/ajco.12826
- Prognostic Value of microRNA-133a Expression and Its Clinicopathologic Significance in Non-Small Cell Lung Cancer: A Comprehensive Study Based on Meta-Analysis and the TCGA Database vol.41, pp.12, 2018, https://doi.org/10.1159/000492343
- Histopathologic quantification of viable tumor versus treatment effect in surgically resected recurrent glioblastoma pp.1573-7373, 2018, https://doi.org/10.1007/s11060-018-03050-6
- Ki-67 expression in mature B-cell neoplasms: a flow cytometry study vol.64, pp.6, 2018, https://doi.org/10.1590/1806-9282.64.06.525
- CEST-MRI for glioma pH quantification in mouse model: Validation by immunohistochemistry vol.31, pp.11, 2018, https://doi.org/10.1002/nbm.4005
- Radiomics based on multicontrast MRI can precisely differentiate among glioma subtypes and predict tumour-proliferative behaviour pp.1432-1084, 2018, https://doi.org/10.1007/s00330-018-5704-8
- Imaging characteristics of cerebral extraventricular neurocytoma with pathological correlation pp.1573-7373, 2018, https://doi.org/10.1007/s11060-018-2952-z
- A novel enhancer regulates MGMT expression and promotes temozolomide resistance in glioblastoma vol.9, pp.1, 2018, https://doi.org/10.1038/s41467-018-05373-4
- Differential somatostatin, CXCR4 chemokine and endothelin A receptor expression in WHO grade I–IV astrocytic brain tumors vol.144, pp.7, 2018, https://doi.org/10.1007/s00432-018-2645-1
- Standard diffusion-weighted, diffusion kurtosis and intravoxel incoherent motion MR imaging of sinonasal malignancies: correlations with Ki-67 proliferation status vol.28, pp.7, 2018, https://doi.org/10.1007/s00330-017-5286-x
- Multimodal imaging-defined subregions in newly diagnosed glioblastoma: impact on overall survival vol.21, pp.2, 2018, https://doi.org/10.1093/neuonc/noy169